| Literature DB >> 34738636 |
Scarlet Brockmoeller1, Amelie Echle2, Narmin Ghaffari Laleh2, Susanne Eiholm3, Marie Louise Malmstrøm4, Tine Plato Kuhlmann5, Katarina Levic6, Heike Irmgard Grabsch1,7, Nicholas P West1, Oliver Lester Saldanha2, Katerina Kouvidi1, Aurora Bono1, Lara R Heij7,8,9, Titus J Brinker10, Ismayil Gögenür11,12, Philip Quirke1, Jakob Nikolas Kather1,2,13.
Abstract
The spread of early-stage (T1 and T2) adenocarcinomas to locoregional lymph nodes is a key event in disease progression of colorectal cancer (CRC). The cellular mechanisms behind this event are not completely understood and existing predictive biomarkers are imperfect. Here, we used an end-to-end deep learning algorithm to identify risk factors for lymph node metastasis (LNM) status in digitized histopathology slides of the primary CRC and its surrounding tissue. In two large population-based cohorts, we show that this system can predict the presence of more than one LNM in pT2 CRC patients with an area under the receiver operating curve (AUROC) of 0.733 (0.67-0.758) and patients with any LNM with an AUROC of 0.711 (0.597-0.797). Similarly, in pT1 CRC patients, the presence of more than one LNM or any LNM was predictable with an AUROC of 0.733 (0.644-0.778) and 0.567 (0.542-0.597), respectively. Based on these findings, we used the deep learning system to guide human pathology experts towards highly predictive regions for LNM in the whole slide images. This hybrid human observer and deep learning approach identified inflamed adipose tissue as the highest predictive feature for LNM presence. Our study is a first proof of concept that artificial intelligence (AI) systems may be able to discover potentially new biological mechanisms in cancer progression. Our deep learning algorithm is publicly available and can be used for biomarker discovery in any disease setting.Entities:
Keywords: AI; artificial intelligence; deep learning; digital pathology; early colorectal cancer; inflamed adipose tissue; metastasis; new predictive biomarker; pT1 and pT2 bowel cancer; prediction LNM
Mesh:
Year: 2021 PMID: 34738636 DOI: 10.1002/path.5831
Source DB: PubMed Journal: J Pathol ISSN: 0022-3417 Impact factor: 7.996